News

What if a simple antioxidant could help tackle one of COVID-19's deadliest complications—immunothrombosis? Dive into the science behind liposomal glutathione and its potential to revolutionize COVID-19 treatment.

A recent study hints at good news: omega-3 supplements could help prevent mental health problems after COVID-19.

The pathogen of COVID-19 enters cells through binding to the Angiotensin Converting Enzyme 2 (ACE2) (Aksoy H, et.al., 2020). ACE2 is highly expressed in adipose tissue. This contributes to increased viral transmission in COVID-19 patients with obesity. The following study investigated the effects of 30-days resveratrol supplementation in men with...

A common denominator in all conditions associated with COVID-19 appears to be the impaired redox homeostasis responsible for reactive oxygen species accumulation causing free radical damage; therefore, levels of glutathione, the key anti-oxidant guardian in all tissues, could be critical in extinguishing the exacerbated inflammation that triggers organ failure in...

  A huge amount of research has been produced on the COVID 19. It is so much that it is impossible for someone to read all of it. That’s why researchers in Switzerland implemented the use of artificial intelligence to access relevant information from a huge number of studies. The...

  Magnesium is important for activating vitamin D and has a protective role against oxidative stress, both are important for a healthy immune response (DiNicolantonio JJ, O'Keefe JH, 2021). Vitamin D is also important for reducing the risk of upper respiratory tract infections. Magnesium deficiency increases endothelial cell susceptibility to...

  Mitochondrial disorders play a central role in many diseases. The mitochondria is the energy producing entity of the cells. These researchers explained that it is vitally important for the cells to have optimal levels of glutathione in the mitochondria to prevent cellular dysfunction (Mari M, et al., 2020). A...

  This study included non-critically ill patients hospitalized with COVID-19 (Carrasco-Sánchez F, et al., 2021). 11,312 patients were categorized into three groups according to their blood glucose levels: Less than 140 mg/dL, between 140-180 mg/dL and more than 180 mg/dL. Only 2128 of these patients had diabetes. This is what...